Ethambutol HCl

• CAT Number: A000227
• CAS Number: 1070-11-7
• Molecular Formula: C10H24N2O2.2HCl
• Molecular Weight: 277.23
• Purity: ≥95%
• Synonyms: CL40881
• Target: Anti-infection
• Storage: 3 years -20C powder
• IUPAC Name: (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;dihydrochloride
• InChI: InChI=1S/C10H24N2O2.2ClH/c1-3-9(7-13)11-5-6-12-10(4-2)8-14;;/h9-14H,3-8H2,1-2H3;2*1H/t9-,10-;;/m0../s1
• InChIKey: AUAHHJJRFHRVPV-BZDVOYDHSA-N
• SMILES: CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl

Ethambutol HCl（Cat No.:A000227）is an effective antimycobacterial agent used primarily in the treatment of tuberculosis (TB). It inhibits cell wall synthesis in Mycobacterium tuberculosis, thereby limiting bacterial growth. This hydrochloride salt form enhances solubility and absorption, ensuring optimal bioavailability. Ethambutol HCl works synergistically with other TB drugs to prevent resistance, often used alongside isoniazid, rifampicin, and pyrazinamide. Its targeted action is crucial for early-stage TB treatment, providing a valuable tool for both initial and continuation phases in TB therapy. Suitable for research in drug-resistant TB mechanisms.

Reference

1: El-Ridy MS, Yehia SA, Kassem MA, Mostafa DM, Nasr EA, Asfour MH. Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety. Drug Deliv. 2015 Jan;22(1):21-36. doi: 10.3109/10717544.2013.868556. Epub 2013 Dec 20. PubMed PMID: 24359403.2: Chellini PR, Lages EB, Franco PH, Nogueira FH, César IC, Pianetti GA. Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations. J AOAC Int. 2015 Sep-Oct;98(5):1234-9. doi: 10.5740/jaoacint.14-237. PubMed PMID: 26525241.3: Wang HF, Wang R, O/’Gorman M, Crownover P, Naqvi A, Jafri I. Bioequivalence of fixed-dose combination Myrin®-P Forte and reference drugs in loose combination. Int J Tuberc Lung Dis. 2013 Dec;17(12):1596-601. doi: 10.5588/ijtld.13.0190. PubMed PMID: 24200275.4: Bakayoko AS, Kaloga M, Kamagate M, Kone Z, Daix AT, Ohui E, Gbery I, Domoua K. [Fixed drug eruption after taking ethambutol]. Rev Mal Respir. 2015 Jan;32(1):48-51. doi: 10.1016/j.rmr.2014.03.011. Epub 2014 Apr 29. French. PubMed PMID: 25618204.5: Sun J, Song H, Zhang T, Wang Z, He Z. [Determination of contents and dissolution of ethambutol hydrochloride in fixed dose combinations for antituberculosis drugs by high performance liquid chromatography with pre-column derivatization]. Se Pu. 2006 Mar;24(2):164-7. Chinese. PubMed PMID: 16830466.6: Lee SY, Jang H, Lee JY, Kwon KI, Oh SJ, Kim SK. Inhibition of cytochrome P450 by ethambutol in human liver microsomes. Toxicol Lett. 2014 Aug 17;229(1):33-40. doi: 10.1016/j.toxlet.2014.06.006. Epub 2014 Jun 5. PubMed PMID: 24910189.7: Yan M, Guo T, Song H, Zhao Q, Sui Y. Determination of ethambutol hydrochloride in the combination tablets by precolumn derivatization. J Chromatogr Sci. 2007 May-Jun;45(5):269-72. PubMed PMID: 17555635.8: Veríssimo LM, Cabral AM, Veiga FJ, Almeida SF, Ramos ML, Burrows HD, Esteso MA, Ribeiro AC. Transport properties in aqueous ethambutol dihydrochloride. Int J Pharm. 2015 Feb 20;479(2):306-11. doi: 10.1016/j.ijpharm.2014.12.053. Epub 2014 Dec 26. PubMed PMID: 25545796.9: Tan HS, Gerlach ED, Dimattio AS. Sensitive assay procedure for ethambutol hydrochloride via charge transfer complex formation. J Pharm Sci. 1977 Jun;66(6):766-9. PubMed PMID: 874773.10: Yen YF, Chung MS, Hu HY, Lai YJ, Huang LY, Lin YS, Chou P, Deng CY. Association of pulmonary tuberculosis and ethambutol with incident depressive disorder: a nationwide, population-based cohort study. J Clin Psychiatry. 2015 Apr;76(4):e505-11. doi: 10.4088/JCP.14m09403. PubMed PMID: 25919843.11: Ragonese R, Macka M, Hughes J, Petocz P. The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. J Pharm Biomed Anal. 2002 Mar 1;27(6):995-1007. PubMed PMID: 11836062.12: Shingbal DM, Naik SD. Colorimetric determination of ethambutol hydrochloride. J Assoc Off Anal Chem. 1982 Jul;65(4):899-900. PubMed PMID: 7118796.13: Ahmad MI, Nakpheng T, Srichana T. The safety of ethambutol dihydrochloride dry powder formulations containing chitosan for the possibility of treating lung tuberculosis. Inhal Toxicol. 2014 Dec;26(14):908-17. doi: 10.3109/08958378.2014.975875. PubMed PMID: 25472479.14: Mukherjee A, Velpandian T, Singla M, Kanhiya K, Kabra SK, Lodha R. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children. BMC Infect Dis. 2015 Mar 14;15:126. doi: 10.1186/s12879-015-0862-7. PubMed PMID: 25887748; PubMed Central PMCID: PMC4373095.15: He L, Wang X, Cui P, Jin J, Chen J, Zhang W, Zhang Y. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2015 Mar;95(2):149-54. doi: 10.1016/j.tube.2014.12.002. Epub 2014 Dec 13. PubMed PMID: 25547657.16: Moure R, Español M, Tudó G, Vicente E, Coll P, Gonzalez-Martin J, Mick V, Salvadó M, Alcaide F. Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array. J Antimicrob Chemother. 2014 Apr;69(4):947-54. doi: 10.1093/jac/dkt448. Epub 2013 Nov 11. PubMed PMID: 24216765.17: Evaluation of a new antituberculous agent. Ethambutol hydrochloride (Myambutol). JAMA. 1969 Jun 30;208(13):2463-4. PubMed PMID: 4977611.18: Ethambutol hydrochloride (myambutol). Med Lett Drugs Ther. 1968 May 31;10(11):41-2. PubMed PMID: 5656613.19: P Brock A, Isaza R, Egelund EF, Hunter RP, Peloquin CA. The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus). J Vet Pharmacol Ther. 2014 Oct;37(5):472-9. doi: 10.1111/jvp.12119. Epub 2014 Mar 29. PubMed PMID: 24684601.20: Levy M, Rigaudière F, de Lauzanne A, Koehl B, Melki I, Lorrot M, Faye A. Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution. Pediatr Infect Dis J. 2015 Apr;34(4):346-50. doi: 10.1097/INF.0000000000000589. PubMed PMID: 25764095.